A detailed history of Logos Global Management LP transactions in Cybin Inc. stock. As of the latest transaction made, Logos Global Management LP holds 40,000,000 shares of CYBN stock, worth $480 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares
40,000,000
Previous 40,000,000 -0.0%
Holding current value
$480 Million
Previous $10.8 Million -0.0%
% of portfolio
1.01%
Previous 1.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.3 - $0.46 $12 Million - $18.4 Million
40,000,000 New
40,000,000 $16.4 Million

Others Institutions Holding CYBN

About CYBIN INC.


  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $1.99B
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.